Healthcare -
Biotechnology - NASDAQ - US
$ 5.17
2.64 %
$ 461 M
Market Cap
-1.63
P/E
AMLX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities AMLX - Amylyx Pharmaceuticals, Inc.
348 K
LAST VALUE
-97.16%
2 YEAR CAGR
-12.23%
5 YEAR CAGR
0.00%
10 YEAR CAGR